1.Efficacy of compound Xueshuantong combined laser therapy on central serous chorioretinopathy
International Eye Science 2014;(10):1841-1843
AIM: To explore the clinical therapeutic effect of compound Xueshuantong combined with laser treatment in central serous chorioretinopathy ( CSCR) patients.
METHODS: A total of 181 cases of central serous chorioretinopathy patients treated in our hospital were randomly divided into treatment group ( 91 cases ) and control group ( 90 cases ) . The patients in control group underwent laser treatment, those in treatment group received oral compound Xueshuantong after laser treatment. Clinical curative effect, the average light sensitivity and serum testosterone, estrogen levels of two group were compared.
RESULTS: After 3wk of treatment, the total effective rate of the treatment group was 90. 1%, 72. 2% in the control group, the treatment group was significantly higher (χ2 = 10. 473, P= 0. 001 ); After 6wk of treatment group, the total effective rate was also significantly higher than that in the control group (χ2 = 4. 499, P= 0. 034). Healing time, visual recovery time in treatment group was significantly less than those in the control group, the mean sensitivity was significantly higher, the difference between the two groups was statistical significance ( P<0.05). After the treatment the hormone of patients in the two groups were significantly decreased, the treatment to reduce the level of serum hormone level was significantly better than those in the control group, the difference between the two groups was statistical significance ( P<0.05).
CONCLUSION: Compound Xueshuantong combined with laser in the treatment of central serous chorioretinopathy, can significantly improve the efficacy, shorten the course of disease, is conducive to the recovery of visual function, and worth the clinical promotion.
2.Expression level of Annexin Ⅱ in lung cancer tissue, bronchoalveolar lavage fluid and pleural effusion and its value in the diagnosis of lung cancer
Clinical Medicine of China 2017;33(6):530-533
Objective To investigate the expression level of Annexin Ⅱ in bronchial lung cancer tissue,alveolar lavage fluid(BALF) and pleural effusion and its value in the diagnosis of lung cancer.Methods From January 2014 to March 2016 in Jingzhou Infectious Disease Hospital,80 cases of patients with pleural effusion of lung cancer (Lung Cancer Group),40 patients with benign pleural effusion (benign group) were chose.The expression level of Annexin of two groups of patients with pleural effusion,BALF were detected and compared.Sixty specimens of department of pathology past (after lung cancer surgery cancer) and 30 cases of previously collected normal lung tissues (normal lung tissue) were collected,differential expression by immunohistochemical staining were compared between the two groups of Annexin Ⅱ protein.Results The positive expression of Annexin Ⅱ in lung cancer was 61.67% (37/60),higher than that in normal lung tissue of 23.33% (7/30),the difference was statistically significant(P<0.001).The positive expression of Annexin Ⅱ in lung cancer patients was significantly correlated with rate of lymph node metastasis and clinical stage of lung cancer(P =0.039,0.029).Group of patients with pleural effusion,BALF expression of Annexin Ⅱ the level was higher than that in benign group(P<0.001).When the critical value of Annexin in pleural effusion of lung cancer diagnosis was 10.94 μg/L,the sensitivity of diagnosis of lung cancer was 83.47%,the specificity was 80.66%,AUC value was 0.837.The critical value when BALF Annexin Ⅱ in the diagnosis of lung cancer was 52.08 μg/L,the sensitivity of diagnosis of lung cancer was 86.19%,the specificity was 89.22%,the AUC value was 0.898.Conclusion The expression level of Annexin Ⅱ in the BALF and pleural effusion of patients with bronchial lung cancer and lung cancer is increased,and it has a certain clinical value for the differential diagnosis of lung cancer.
3.Effects of terlipressin in the management of ascites after hepatectomy: a prospective trial
Chinese Journal of Digestive Surgery 2012;(6):518-521
Objective To investigate the efficacy of terlipressin in the management of ascites after hepatectomy.Methods Fifty-four patients with hepatic cancer who were admitted to the Union Hospital of Tongji Medical College from January 2010 to January 2011 were randomly divided into the research group (28 patients) and control group (26 patients) according to the random number table.Patients in the research group were treated by the terlipressin and albumin,and patients in the control group were treated by furosemide and albumin.The volume of ascites,urine output,renal function,electrolyte balance,recovery after hepatectomy and complications of the 2 groups were investigated.All data were analyzed by the t test,chi-square test or Fisher exact probability.Results The volume of postoperative maximum drainage was (351 ± 174) ml in the research group,which was significantly lesser than (551 ±233)ml in the control group (t =3.604,P < 0.05).The total urine output of the research group was significantly higher than that of the control group at postoperative day 1 and day 3 (t =5.816,2.722,P < 0.05).All patients had normal renal function except 1 patient was complicated by hepatorenal syndrome in the control group.Electrolyte imbalance was observed in 3 patients (11%) in the research group and 9 patients (35%) in the control group,with a significant difference (x2 =4.456,P < 0.05).The postoperative time of intensive care unit stay and the anal exsufflation time of the research group were (22 ± 12)hours and (68 ±24)hours,which were similar to (23 ± 10)hours and (76 ±28)hours of the control group (t =0.331,1.130,P >0.05).The abdominal drainage tube removal time and hospital stay of the research group were (102 ± 42)hours and (15 ±4)days,which were significantly shorter than (140 ±50) hours and (18 ±5)days (t =3.032,2.443,P < 0.05).There were 1 patient in the research group complicated with high blood pressure and 1 patient in the control group with cardiac arrhythmia.The incidences of adverse reaction were 4% (1/28) in the research group and 4% (1/26) in the control group,with no significant difference (P > 0.05).Conclusion Terlipressin is effective in the management of ascites after hepatectomy,has less effect on electrolyte balance and is beneficial to quick recovery.
4.Interactions between angiotensin converting enzyme inhibitors and aspirin
Xiong-Wen LV ; Jun LI ;
Chinese Pharmacological Bulletin 1987;0(01):-
Both aspirin and angiotensin converting enzyme(ACE)inhi bi tors are often used concomitantly in patients with cardiovascular disease.The s afety of the combination has been questioned. The potential antagonistic interac tions between ACE inhibitors and aspirin has become the focus of both increasing research and intense debate,with conflicting conclusions havin g been reported in the literature.We reviewed systematically available literatu re on the interactions between ACE inhibitors and aspirin in hyper- tension,acute myocardial infarction and congestive heart failure and found that further trials are needed to shed light on the effects and mechanism of interaction between these drugs.
5.Effect of low dose of dexamethasone combined with mannitol on early swelling of oral and maxillofacial injuries
Chinese Journal of Biochemical Pharmaceutics 2017;37(7):202-203,206
Objective To explore the effect of low dose of dexamethasone and mannitol on the early swelling of oral and maxillofacial injuries.Methods A total of 100 patients with oral and maxillofacial injuries who were treated in Huanggang City Center Hospital from February 2015 to January 2016 were divided into two groups by means of an envelope randomized group.Group 50 patients, group A patients received low doses of dexamethasone treatment, B group of patients on the basis of increased mannitol for treatment, compared the efficacy of both groups of patients with maxillofacial swelling improved.Results The clinical general improvement probability of group B was significantly higher than that of group A, and the distance between the horizontal direction and the vertical direction of group B was significantly higher than that of group A (P<0.05).Conclusion The combination of low dose dexamethasone and mannitol has a great effect on the early swelling of oral and maxillofacial injury, and it is worthy to be further implemented in the future clinical practice.
6.Clinical effects of joint injection therapy, ultrashort wave physical therapy and oral medication on temporomandibular joint osteoarthritis
Chinese Journal of Biochemical Pharmaceutics 2017;37(8):338-339,341
Objective To observe and analyze the clinical effects of joint injection therapy, ultrashort wave physical therapy and oral medication on temporomandibular joint osteoarthritis. Methods From September 2014 to September 2016 in Huanggang central hospital of Hubei province, 120 patients with osteoarthritis of the temporomandibular joint were divided into 3 groups according to the different treatment methods, 40 cases in each group. The injection group were treated with a joint cavity injection, The ultrashort wave group were given ultrashort wave physiotherapy, and the drug group were given oral medication. The effects and the temporomandibular joint function (DI) values were compared in the 3 groups at 1, 3 and 6 months after treatment. Results 1 months after treatment, the total effective rate in the injection group was 92.50%, 90%in the ultrashort wave group, and 72.50% in the drug group. The total effective rate in the injection group and the ultrashort wave group were better than that in the drug group (P<0.05); 3 and 6 months after treatment, the total effective rate was 90% and 95% in the injection group, which were better than those in the other 2 groups (P<0.05); DI value in the injection group was (0.17 ±0.04), (0.18±0.03), which were significantly better than the other 2 groups (P<0.05). Conclusion The effect is better which joint cavity injection was used in the treatment of temporomandibular joint osteoarthritis. It has good stability and is worthy of further popularization and application
7.Effect of ephedrine on expression of eotaxin in human bronchial epithelial cells stimulated by tumor necrosis factor-α
Zhongyan LI ; Jun DENG ; Bin XIONG ; Ying XIONG ; Songping WANG
Chongqing Medicine 2016;45(8):1016-1018
Objective To observe the effect of ephedrine on the expression of eotaxin in human bronchial epithelial cells (16HBE) stimulated by tumor necrosis factor‐α(TNF‐α) and to explore the mechanism of Chinese medicine ephedra in treating asthma .Methods The in vitro cultured 16HBE were randomly divided into the control group ,TNF‐αstimulation group(TNF‐α20 ng/mL) and TNF‐αplus ephedrine group (TNF‐α20 ng/mL plus ephedrine 300 μg/mL) .Three complex holes in each group were set to culture for 18 h ,the eotaxin mRNA expression was measured by real time fluorescent quantified PCR and protein level was detected by immunocytochemical stain and Western blot .The eotaxin concentration in cells culture supernatant was quantified by ELISA .Results Compared with the the control group ,the expression level of eotaxin mRNA and protein ,and the concentration of eotaxin in cell culture supernatant in the TNF‐α stimulation group were increased obviously ,there being statisticaly significant difference between them(P<0 .01);however ,all above these parameters in the TNF‐αplus ephedrine group showed decreased obvi‐ously as compared with the TNF‐αgroup ,the difference between them was statistically significant (P<0 .01) .Conclusion Ephed‐rine can inhibit the expression and secretion of eotaxin in TNF‐α induced 16HBE inflammatory model ,which may be one of the mechanisms of Chinese medicine ephedra in treating asthma .
8.Preparation and in vitro Drug Release of Betahistine Dihydrochloride Sustained-release Matrix Tablets
Kai LI ; Ying CHEN ; Jun CHAI ; Yun XIONG ; Jiao XIONG
China Pharmacist 2014;(10):1665-1668,1669
Objective: To prepare betahistine dihydrochloride sustained-release matrix tablets. Methods: The tablets were pre-pared with water soluble HPMC matrix, and the release behaviors were investigated by single factor study. The formula and preparation procedures were optimized by orthogonal design. Results:The optimal technology was as follows:using 60% HPMC K15M as the ma-trix material, calcium hydrogen phosphate as the filler, 10% PVP in 90% alcohol as the bonding agent;wet granulation compression technique was used to prepare the tablets with the tablet weight of 500mg. The in vitro drug release fits a Higuchi equation and the drug can be sustained-released within 12 h. Conclusion:The preparation technology is simple and the tablets have sustainol release behav-ior.
9.Quality Evaluation of Randomized Controlled Trails Papers on Acupuncture and Moxibustion for Vertebrobasilar Insufficiency
Lihong YANG ; Bo LI ; Jun XIONG
Chinese Journal of Information on Traditional Chinese Medicine 2006;0(10):-
Objective To evaluate the quality of clinical trials about acupuncture and moxibustion treatment of vertebrobasilar insufficiency in China.Methods Literature of clinical trials of acupuncture was collected and analyzed,evaluated by the randomized controlled test criteria and the clinical assessing method in Cochrane handbook of international Cochrane cooperation net.Results Sixteen literatures were brought in.87.5% of the included literature had no clear description of random methods,and no allocation concealment,use of blind methods,sample size calculation,intention-to-treat analysis.Among them,62.5% had explicit diagnosis criteria,12.5% with correct randomizing method,62.5% with explicit evaluation criteria,however,31.22% with no words referring to the comparability among the groups.Conclusions Though acupuncture and moxibustion have been widely applied in prevention and treatment of vertebrobasilar insufficiency,it can not provide evidences of higher reliability for clinical treatment due to less clinical randomized controlled tests and lower quality,which severely hinder testing and verifying of clinical therapeutic effects of acupuncture and moxibustion.It is proposed that multiple central and randomized controlled test should be made,so as to search for feasible acupuncture and moxibustion methods with definite therapeutic effect for vertebrobasilar insufficiency,and provide basis for further systematical evaluation.
10.Clinical study on the timing of postoperative parenteral nutrition support in patients of gastrointestinal neoplasms
Jun BU ; Xiong HUANG ; Nian LI
Chinese Journal of General Surgery 2013;(4):276-279
Objective To evaluate the timing of postoperative parenteral nutrition support for gastrointestinal tumor patients with a definite nutritional risk.Methods Using a randomized control clinical research methods,80 gastrointestinal cancer patients were randomly divided into study group (40 cases) and control group (40 cases).In the study group parenteral nutrition support started on postoperative day 2,while in the control group it started on postoperative day 1.Flatus passing,the rate of infectious complications,the rate of systemic inflammatory response syndrome,postoperative nutrition support related expenses,and the duration of postoperative hospital stay were recorded.Results There was no significant differences between the two groups (P > 0.05) in age,sex,body mass index,use of glutamine,disease and type of surgery.Compared with the control group,patients in the study group had earlier postoperative flatus passing [(3.33± 1.10) d vs.(4.03 ± 1.51) d,P =0.020],less systemic inflammation response syndrome (8/40 vs.17/40,P =0.030),shorter postoperative hospital stay [(3.33±1.10) d vs.(4.03±1.51) d,P=0.020] and lower nutrition support costs [(2144.49 ±1210.96) RMB vs.(2915.99 ± 1615.68) RMB,P =0.018].There was no significant difference in postoperative nutrition index,peristalsis recovery time and infectious complications between the two groups (all P > 0.05).Conclusions In patients undergoing surgery for GI tumors,parenteral nutrition support started on post-op day 2 promotes the recovery of gastrointestinal function,while decreasing medical cost.